Gemini Therapeutics, Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Gemini Therapeutics, Inc. (GMTX) — Frequently Asked Questions

Gemini Therapeutics, Inc. (GMTX) is a publicly traded US company. Explore GMTX's stock price, financial statements, earnings history, margins and key ratios below.

What is the GMTX stock price?

GMTX trades at $65.75 (-1.87% on the day).